[go: up one dir, main page]

PT1371375E - Vacina para a protecção de animais contra a leishmaníase âmbito técnico - Google Patents

Vacina para a protecção de animais contra a leishmaníase âmbito técnico Download PDF

Info

Publication number
PT1371375E
PT1371375E PT02702414T PT02702414T PT1371375E PT 1371375 E PT1371375 E PT 1371375E PT 02702414 T PT02702414 T PT 02702414T PT 02702414 T PT02702414 T PT 02702414T PT 1371375 E PT1371375 E PT 1371375E
Authority
PT
Portugal
Prior art keywords
leishmania
vaccine
animals against
protect animals
against leishmania
Prior art date
Application number
PT02702414T
Other languages
English (en)
Inventor
V E Larraga Rodriguez De Vera
G Gonzalez Aseguinolaza
M J Ramiro Ibanez
J A Castillo Hernandez
J Lucientes Curdi
Original Assignee
Consejo Superior Investigacion
Univ Zaragoza
Hipra Lab Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from ES200100402A external-priority patent/ES2171360B1/es
Application filed by Consejo Superior Investigacion, Univ Zaragoza, Hipra Lab Sa filed Critical Consejo Superior Investigacion
Publication of PT1371375E publication Critical patent/PT1371375E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/20Interleukins [IL]
    • A61K38/208IL-12
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/002Protozoa antigens
    • A61K39/008Leishmania antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5256Virus expressing foreign proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53DNA (RNA) vaccination
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55522Cytokines; Lymphokines; Interferons
    • A61K2039/55527Interleukins
    • A61K2039/55538IL-12
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/57Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00Uses of viruses
    • C12N2799/02Uses of viruses as vector
    • C12N2799/021Uses of viruses as vector for the expression of a heterologous nucleic acid
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
PT02702414T 2001-02-21 2002-02-21 Vacina para a protecção de animais contra a leishmaníase âmbito técnico PT1371375E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200100402A ES2171360B1 (es) 2001-02-21 2001-02-21 Vacuna para la proteccion de animales frente a la leishmania.
ES200102057A ES2172482B1 (es) 2001-02-21 2001-09-12 Adicion de la patente es200100402 "vacuna para la proteccion de perros frente a la leishmania".

Publications (1)

Publication Number Publication Date
PT1371375E true PT1371375E (pt) 2009-10-12

Family

ID=26156220

Family Applications (1)

Application Number Title Priority Date Filing Date
PT02702414T PT1371375E (pt) 2001-02-21 2002-02-21 Vacina para a protecção de animais contra a leishmaníase âmbito técnico

Country Status (6)

Country Link
EP (1) EP1371375B1 (pt)
AT (1) ATE439858T1 (pt)
DE (1) DE60233391D1 (pt)
ES (1) ES2334493T3 (pt)
PT (1) PT1371375E (pt)
WO (1) WO2002066054A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006058243A2 (en) * 2004-11-24 2006-06-01 Yale University Leishmania antigens and related compositions and uses

Also Published As

Publication number Publication date
DE60233391D1 (de) 2009-10-01
EP1371375A1 (en) 2003-12-17
ATE439858T1 (de) 2009-09-15
ES2334493T3 (es) 2010-03-11
WO2002066054A1 (es) 2002-08-29
EP1371375B1 (en) 2009-08-19

Similar Documents

Publication Publication Date Title
GB0118249D0 (en) Histidine vaccines
ATE451119T1 (de) Untereinheit-impfstoff gegen das respiratorische synzytialvirus
WO2002096363A3 (en) Method for treating fibrotic diseases or other indications
WO2004098491A3 (en) METHOD OF PREVENTING INFECTIONS FROM BIOTERRORISM AGENTS WITH IMMUNOSTIMULATORY CpG OLIGONUCLEOTIDES
ATE250937T1 (de) Chitosan und influenza-antigen(e) enthaltende impfstoff-zubereitungen zur verabreichung durch eine mukosa
BRPI9912663B1 (pt) vacina contra cáncer e polipeptìdeo.
MXPA05009580A (es) Vacuna contra el virus de la influenza.
PT1409692E (pt) Novos péptidos do derivados da proteína g do vírus respiratório sincicial (vrs) e sua utilização numa vacina
DK1216053T3 (da) Influenzavaccine
WO2006068663A3 (en) Vaccine compositions for treating coronavirus infection
NZ547776A (en) Modified vaccinia virus ankara for protecting an animal against an antigen or self-protein
ATE270707T1 (de) Entepneumovirus und entsprechendes impfstoff
WO2003059385A3 (en) Hiv vaccine and method of use
WO2002096362A3 (en) Method for treating fibrotic diseases or other indications vi
NO20011193L (no) Vaksine mot seksuelt overförbare sykdommer
WO2003083083A3 (en) Methods of using flt3-ligand in immunization protocols
MXPA03009763A (es) Vacuna contra el virus de la enfermedad de la fiebre aftosa.
WO2001068865A3 (en) Fish vaccine against piscirickettsia salmonis
PT1371375E (pt) Vacina para a protecção de animais contra a leishmaníase âmbito técnico
EA200301151A1 (ru) Вакцина против натуральной оспы
BRPI0412913A (pt) meio para tratamento de infecções por leishmaniose
ES2172482A1 (es) Adicion de la patente es 200100402 vacuna para la proteccion de perros frente a leishmania
WO2001022994A3 (en) Vaccines against neisseria infection
WO2003032917A3 (en) Hookworm vaccine
WO2007121491A8 (en) Hcv vaccinations